Panacea Life Sciences Holdings, Inc. Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss)
Panacea Life Sciences Holdings, Inc. (PLSH) reported Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) of $354.36 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Income Statement › Other Income
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2018-11-14
- Panacea Life Sciences Holdings, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2018-09-30 was $53.20K, a 61.23% increase year-over-year.
- Panacea Life Sciences Holdings, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2018-06-30 was -$119.00K.
- Panacea Life Sciences Holdings, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2018-03-31 was $420.15K.
- Panacea Life Sciences Holdings, Inc. fair value, liability, recurring basis, still held, unrealized gain (loss) for the quarter ending 2017-09-30 was $33.00K.
| Period end | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 3 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 6 month | Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) 9 month |
|---|---|---|---|
| 2018-09-30 | $53.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$65.80K derived: sum of 2 quarters · filed 2018-11-14 | $354.36K 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$119.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-20 | $301.15K 10-Q · filed 2018-08-20 | |
| 2018-03-31 | $420.15K 10-Q · filed 2018-05-21 | ||
| 2017-09-30 | $33.00K 10-Q · filed 2017-11-20 |